Drug
Troriluzole
Troriluzole: highest development phase Phase 3, developed by Biohaven Pharmaceuticals, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biohaven Pharmaceuticals, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| troriluzole NCT03701399 | Phase 3 | Spinocerebellar Ataxias |
Latest
No recent events.
Follow Troriluzole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.